28 | OUTCOMES FROM THE PHASE 3 inMIND STUDY OF TAFASITAMAB (TAFA) PLUS LENALIDOMIDE (LEN) AND RITUXIMAB (R) FOR PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL)

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	L. H. Sehn, K. Hübel, S. Luminari, C. W. Scholz, A. Salar, S. Paneesha, B. E. Wahlin, P. Panayiotidis, H. Lee, A. Jimenez Ubieto, J. Sancho, T. M. Kim, E. Domingo Domenech, T. Kumode, C. Poh, C. Thieblemont, D. Deeren, W. Klapper, L. Sackmann, M. Arbushites, O. Bortolami, D. Alvarez Arias, M. Trneny
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Hematological Oncology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet